Comparison of Different Surgical Treatments for Severe Ptosis Correction
Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Apr 12, 2019
Trial Information
Current as of August 19, 2025
Unknown status
Keywords
ClinConnect Summary
The ptosis is divided into light, medium and severe according to the difference in muscle strength of the upper levator muscle. According to the previous diagnosis and treatment criteria, for the mild and moderate ptosis, it is recommended to use the method of shortening or partial resection of the levator muscle. For severe patients, because the strength of the upper levator muscles are extremely weak, the function of the upper eye lid can only be reconstructed through the strength of the frontal muscles. So it is recommended to use the frontal muscle flap surgery for correct ptosis. Howev...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • unilateral ptosis patient
- • the levator muscle strength less than 4mm
- • primary surgery
- • older than 3 years
- • ocular rectus muscle of good strength;
- Exclusion Criteria:
- • patients who had undergone ptosis correction surgery
- • patients with neurological ptosis, senile ptosis or pseudo ptosis
- • patients with abnormal ocular function
- • patients with Marcus-Gunn syndromes
- • patients with severe systemic disease or intolerant to general anesthesia
- • patients or their parents cannot finish follow-up due to educational level or various other reasons.
About Shanghai Jiao Tong University School Of Medicine
Shanghai Jiao Tong University School of Medicine is a leading academic institution in China, renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, the school leverages its extensive expertise in biomedical sciences and innovative healthcare solutions to conduct rigorous clinical studies aimed at improving patient outcomes. With a focus on collaboration and translational research, the institution fosters partnerships with healthcare providers, industry leaders, and regulatory bodies to ensure the highest standards of scientific integrity and ethical conduct in clinical trials. Through its research initiatives, Shanghai Jiao Tong University School of Medicine strives to contribute significantly to the global medical community and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Jun Yang, MD, Phd
Study Director
Shanghai Ninth People's Hospital, Affliated to Shanghai Jiao Tong University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials